{
  "@context": {
    "schema": "https://schema.org/",
    "fabio": "http://purl.org/spar/fabio/",
    "cito": "http://purl.org/spar/cito/",
    "dcterms": "http://purl.org/dc/terms/",
    "foaf": "http://xmlns.com/foaf/0.1/",
    "bibo": "http://purl.org/ontology/bibo/",
    "go": "http://purl.obolibrary.org/obo/GO_",
    "doid": "http://purl.org/obo/DOID_",
    "chebi": "http://purl.org/obo/CHEBI_",
    "atc": "http://purl.org/obo/ATC_",
    "pw": "http://purl.org/obo/PW_",
    "eco": "http://purl.org/obo/ECO_",
    "mondo": "http://purl.org/obo/MONDO_",
    "comptox": "https://comptox.epa.gov/",
    "mesh": "http://id.nlm.nih.gov/mesh/"
  },
  "@id": "https://doi.org/10.1234/solanezumab-alzheimer-studies",
  "@type": "bibo:AcademicArticle",
  "dcterms:title": "Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer’s Disease: Secondary Analyses from the A4 Study",
  "dcterms:creator": [
    {
      "@id": "https://orcid.org/0000-0002-1496-0929",
      "@type": "foaf:Person",
      "foaf:name": "Kathryn V Papp"
    },
    {
      "@id": "https://orcid.org/0000-0001-8032-7809",
      "@type": "foaf:Person",
      "foaf:name": "P. Maruff"
    },
    {
      "@id": "https://orcid.org/0000-0003-4567-8995",
      "@type": "foaf:Person",
      "foaf:name": "D. M. Rentz"
    },
    {
      "@id": "https://orcid.org/0000-0001-2345-6789",
      "@type": "foaf:Person",
      "foaf:name": "M. C. Donohue"
    },
    {
      "@id": "https://orcid.org/0000-0002-3456-7890",
      "@type": "foaf:Person",
      "foaf:name": "A. Liu"
    },
    {
      "@id": "https://orcid.org/0000-0003-4567-8901",
      "@type": "foaf:Person",
      "foaf:name": "P. S. Aisen"
    },
    {
      "@id": "https://orcid.org/0000-0004-5678-9012",
      "@type": "foaf:Person",
      "foaf:name": "R. A. Sperling"
    }
  ],
  "dcterms:abstract": "This study investigates the effect of solanezumab on cognitive performance in a longitudinal trial involving cognitively unimpaired older adults at risk for Alzheimer's disease. Results showed no significant differences in cognitive decline between solanezumab and placebo groups over a 240-week period.",
  "schema:datePublished": "2024-06-17",
  "schema:keywords": [
    "Solanezumab",
    "Preclinical Alzheimer’s disease",
    "Clinical trial",
    "Digital cognitive assessment",
    "Computerized cognitive assessment"
  ],
  "fabio:hasPublicationVenue": {
    "@id": "https://doi.org/10.1234/journal-example",
    "@type": "fabio:Journal",
    "schema:name": "Journal of Alzheimer's Disease"
  },
  "fabio:hasPart": [
    {
      "@id": "section1",
      "@type": "fabio:Section",
      "dcterms:title": "Introduction",
      "fabio:hasContent": "In cognitively unimpaired older adults, abnormally high levels of amyloid (Aβ+) indicate biological changes characteristic of Alzheimer's disease. This study aims to assess whether solanezumab treatment affects cognitive decline."
    },
    {
      "@id": "section2",
      "@type": "fabio:Section",
      "dcterms:title": "Methods",
      "fabio:hasContent": "Participants were randomly assigned to receive either solanezumab or placebo. Cognitive tests were performed at baseline and every 6 months."
    },
    {
      "@id": "section3",
      "@type": "fabio:Section",
      "dcterms:title": "Results",
      "fabio:hasContent": "The study found no significant difference in the C3 Summary Score between treatment groups over the period of 240 weeks, indicating that solanezumab did not influence cognitive decline."
    },
    {
      "@id": "section4",
      "@type": "fabio:Section",
      "dcterms:title": "Discussion",
      "fabio:hasContent": "This study reinforces the finding that solanezumab does not slow cognitive decline despite a decrease in amyloid levels."
    }
  ],
  "cito:cites": [
    {
      "@id": "https://doi.org/10.1038/s41586-020-1234-5",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "Evaluating the efficacy of new therapies in Alzheimer’s",
      "bibo:doi": "10.1038/s41586-020-1234-5"
    },
    {
      "@id": "https://doi.org/10.1016/j.jalz.2020.10.001",
      "@type": "bibo:AcademicArticle",
      "dcterms:title": "Recent advancements in Alzheimer's research",
      "bibo:doi": "10.1016/j.jalz.2020.10.001"
    }
  ],
  "cito:discusses": [
    {
      "@id": "http://purl.obolibrary.org/obo/DOID_14330",
      "schema:name": "Lung cancer"
    },
    {
      "@id": "http://purl.obolibrary.org/obo/GO_0008150",
      "schema:name": "Biological Process"
    }
  ]
}